Genolution Inc. (KOSDAQ:225220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,663.00
-36.00 (-2.12%)
At close: Mar 6, 2026
-36.04%
Market Cap 29.20B
Revenue (ttm) 9.15B
Net Income (ttm) -8.06B
Shares Out 18.07M
EPS (ttm) -446.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 44,316
Average Volume 75,993
Open 1,703.00
Previous Close 1,699.00
Day's Range 1,650.00 - 1,703.00
52-Week Range 1,542.00 - 3,015.00
Beta 0.17
RSI 28.65
Earnings Date Mar 20, 2026

About Genolution

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/sh... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2006
Employees 75
Stock Exchange KOSDAQ
Ticker Symbol 225220
Full Company Profile

Financial Performance

In 2024, Genolution's revenue was 7.14 billion, a decrease of -26.90% compared to the previous year's 9.76 billion. Losses were -6.83 billion, 23.8% more than in 2023.

Financial Statements

News

There is no news available yet.